Medical News

Surgery

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cannady SB et al. – It is still safest at the authors institution to perform selective neck dissection on patients with N2 neck disease when initially observed to prevent unsalvageable regional recurrence until more accurate interval assessment tools are confirmed.

Related Articles

Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09    Relevance Score: 71%

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09    Relevance Score: 71%

Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09    Relevance Score: 69%

Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09    Relevance Score: 69%

Progesterone receptors identified in vascular malformations of the head and neck
Otolaryngology Head and Neck Surgery, 10/09/09    Relevance Score: 69%

Today in Head and Neck...keeping you current

Skin necrosis in nasal dorsum following rhinoplasty
European Journal of Plastic Surgery, 12/16/09

Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma
Journal of Gastroenterology, 12/15/09

Emerging applications of stereotactic radiotherapy in head and neck cancer
Neurosurgical Focus, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address